Instil Bio, Inc.

TIL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
4 Jun 12, 2026 FORM 4
4 Jun 12, 2026 FORM 4
4 Jun 12, 2026 FORM 4
4 Jun 12, 2026 FORM 4
8-K Jun 11, 2026 8-K
10-Q May 15, 2026 10-Q
8-K May 15, 2026 8-K
ARS Apr 24, 2026 ARS
DEFA14A Apr 24, 2026 DEFA14A
DEF 14A Apr 24, 2026 DEF 14A
8-K Apr 3, 2026 8-K
S-8 Mar 27, 2026 S-8
10-K Mar 27, 2026 10-K
8-K Mar 27, 2026 8-K
SCHEDULE 13G/A Feb 9, 2026
8-K Jan 6, 2026 8-K
10-Q Nov 13, 2025 10-Q
8-K Nov 13, 2025 8-K
4 Sep 12, 2025 FORM 4
144 Sep 10, 2025
10-Q Aug 13, 2025 10-Q
8-K Aug 13, 2025 8-K
SCHEDULE 13G/A Aug 12, 2025
← Newer Page 1 of 10 · 248 filings Older →